Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2001034185) INDUCTION OF MUCOSAL IMMUNITY BY VACCINATION VIA THE SKIN ROUTE
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2001/034185 International Application No.: PCT/US2000/030897
Publication Date: 17.05.2001 International Filing Date: 09.11.2000
Chapter 2 Demand Filed: 01.06.2001
IPC:
A61K 39/145 (2006.01) ,A61K 39/39 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
12
Viral antigens
145
Orthomyxoviridae, e.g. influenza virus
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
39
characterised by the immunostimulating additives, e.g. chemical adjuvants
Applicants:
POWDERJECT VACCINES, INC. [US/US]; 585 Science Drive Madison, WI 53711, US
Inventors:
CHEN, Dexiang; US
BHARGAVA, Sangeeta; US
FULLER, Deborah; US
Agent:
MCCRACKEN, Thomas, P.; PowderJect Technologies Inc. 6511 Dumbarton Circle Fremont, CA 94555, US
Priority Data:
09/437,69110.11.1999US
Title (EN) INDUCTION OF MUCOSAL IMMUNITY BY VACCINATION VIA THE SKIN ROUTE
(FR) INDUCTION D'UNE IMMUNITE AU NIVEAU DES MUQUEUSES PAR VACCINATION PERCUTANEE
Abstract:
(EN) Methods for generating an immune response at a mucosal surface are described. Compositions suitable for use in the methods for generating an immune response at a mucosal surface are also described. In addition, methods for treating or preventing a disease caused by the entry of a pathogen into the body of a subject via a mucosal surface are provided.
(FR) L'invention concerne des méthodes destinées à générer une réponse immunitaire au niveau d'une surface muqueuse. L'invention concerne également les compositions qu'il convient d'utiliser dans le cadre desdites méthodes destinées à générer une réponse immunitaire au niveau d'une surface muqueuse. En outre, l'invention concerne des méthodes de traitement ou de prévention d'une maladie causée par la pénétration d'un agent pathogène dans le corps d'un sujet via une surface muqueuse.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, UZ, VN, YU, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)